Clinical validation of <scp>C<sub>12</sub>FDG</scp> as a marker associated with senescence and osteoarthritic phenotypes
William S. Hambright(Steadman Philippon Research Institute), Johnny Huard(Steadman Philippon Research Institute)
Cited by 17
Related Papers
CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors
|Stem Cells|2019|43
The use of heparin/polycation coacervate sustain release system to compare the bone regenerative potentials of 5 BMPs using a critical sized calvarial bone defect model
|Biomaterials|2022|33
Specific reprogramming of alpha cells to insulin-producing cells by short glucagon promoter-driven Pdx1 and MafA
|Molecular Therapy — Methods & Clinical Development|2023|23